Yohei Nakaya

NS-187, a potent and selective dual Bcr-Abl/Lyn tyrosine kinase inhibitor, is a novel agent for imatinib-resistant leukemia

Shinya Kimura, Haruna Naito, Hidekazu Segawa et al. · Blood · 2005 · 244 citations · Full text

Medicine, Oncology, Pharmacology +7

Multimodal tangential migration of neocortical GABAergic neurons independent of GPI-anchored proteins

Daisuke H. Tanaka, Yohei Nakaya, Yuchio Yanagawa et al. · Development · 2003 · 165 citations · Full text

Medicine, Neurobiology, Neuroscience +17

In vivo antiproliferative effect of NS-187, a dual Bcr-Abl/Lyn tyrosine kinase inhibitor, on leukemic cells harbouring Abl kinase domain mutations

Haruna Naito, Shinya Kimura, Shinya Kimura et al. · Leukemia Research · 2006 · 50 citations

Medicine, Oncology, Pharmacology +15

Efficacy of NS-018, a potent and selective JAK2/Src inhibitor, in primary cells and mouse models of myeloproliferative neoplasms

Yohei Nakaya, Kotaro Shide, T. Niwa et al. · Blood Cancer Journal · 2011 · 46 citations · Full text

Medicine, Oncology, Pharmacology +16

Effect of NS-018, a selective JAK2V617F inhibitor, in a murine model of myelofibrosis

Yohei Nakaya, Kotaro Shide, H. Naito et al. · Blood Cancer Journal · 2014 · 27 citations · Full text

Medicine, Cell Biology, Hematology +14